# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Fyodor Dostoevsky (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI018-SYN-TD
- Date: 1865-05-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Agnes Lindahl, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-month review on lamotrigine, with a trough level. **S**

## History of present illness

Mr. Dostoevsky returns nine weeks after starting lamotrigine; he has taken 100 mg twice daily for three weeks. He had one generalized seizure in the third week of the titration, while on 50 mg a day, after a night without sleep to finish a manuscript; a friend who was with him timed it at about two minutes and followed the seizure action plan. He has had none since reaching 150 mg a day. He has had no rash, mouth sores, or fever, and no dizziness or double vision. The sleep-deprived EEG six weeks ago was normal. He has not gambled. He has attended every weekly therapy session and is learning to spot the thoughts that lead him to chase losses. He went to two Gamblers Anonymous meetings and saw the debt counselor, who is drawing up a repayment plan. His mood is better. He has no thoughts of suicide. **S**

| Element | Detail |
|---|---|
| Seizures | One in week three of the titration, after sleep loss; none since |
| Lamotrigine | 100 mg twice daily for three weeks; no rash or other side effects |
| Gambling | None for nine weeks; therapy weekly |
| Mood | PHQ-9 6 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | One seizure in week three of the titration; no dizziness, double vision, or unsteadiness |
| Integumentary | Negative | No rash or mouth sores |
| Psychiatric | Negative | Mood better; fewer urges; no thoughts of suicide or self-harm |

3 systems reviewed. **S**

## Current medications

- Lamotrigine 100 mg tablet, one tablet twice daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/76 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 68.8 kg; BMI 23.8 kg/m². All vital signs are synthetic.

Lamotrigine level: 6.2 ug/mL; PHQ-9: 6. All results are synthetic.

## Change since baseline

- PHQ-9: 8 at baseline, 6 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well and relaxed; weight 68.8 kg; blood pressure 118/76, heart rate 70 |
| Skin | No rash on the trunk, limbs, or face |
| Mouth | No ulcers |
| Neurological | No nystagmus or ataxia; tandem gait normal |
| Psychiatric | Euthymic; organized; good insight |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Epilepsy of unknown type on lamotrigine** (G40.909). Maintenance dose reached without rash. The one seizure came early in the titration, at a low dose and after sleep loss. Trough level 6.2 ug/mL at steady state, recorded as his reference level. Sleep-deprived EEG normal. **S**
   - Continue lamotrigine 100 mg twice daily.
   - Keep the seizure diary.
   - No writing through the night.
2. **Gambling disorder** (F63.0). Abstinent for nine weeks, engaged in therapy and peer support. Safety reviewed: no thoughts of suicide. **S**
   - Continue weekly therapy and Gamblers Anonymous.
   - Keep the self-exclusion and the bank block in place.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Seizure frequency, seizure diary, and seizure description | Every visit | Completed today | One seizure in week three of the titration after sleep loss; none since reaching 150 mg a day |
| Medication safety | Antiseizure medicine adverse effects (dizziness, double vision, unsteadiness, sleep, mood) | Every visit | Completed today | No dizziness, double vision, unsteadiness, or sleep change |
| Medication safety | Rash and mouth-sore check (lamotrigine) | Every contact during titration and the first two months, then with symptoms | Completed today | No rash or mouth sores |
| Medication safety | Contact at each lamotrigine dose step to check for rash | At each dose increase during titration | Deferred | No contact was scheduled during the six-week titration, a deviation from the plan to check for rash at each dose step. He knew to stop and call for any rash, and none occurred, so no harm resulted. Corrective action: a nurse telephone check at each step of any future titration |
| Medication safety | Adherence and missed doses | Every visit | Completed today | No missed doses; pill organizer and phone alarms |
| Laboratory | Lamotrigine trough level | Once at steady state as a reference, then with breakthrough seizures, suspected nonadherence, or interacting medicines | Completed today | 6.2 ug/mL trough at steady state; recorded as his reference level |
| Imaging | EEG (routine, then sleep-deprived if normal) | At diagnosis | Up to date | Sleep-deprived EEG six weeks ago normal, with no epileptiform discharges |
| Self-management | Trigger review: sleep loss, alcohol, overwork, missed doses | Every visit | Completed today | The titration seizure followed a night without sleep; he now stops writing by midnight |
| Self-management | Seizure safety and driving counseling | At diagnosis and every visit | Completed today | Not driving; precautions followed |
| Self-management | Written seizure action plan for the people around him | At diagnosis, then yearly | Up to date | Used by a friend during the seizure in March |
| Survey | Depression screen (PHQ-9) | At intake, then every two to four months while symptoms are present | Completed today | PHQ-9 6, item 9 scored 0 |
| Survey | Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline | Every visit (gambling disorder and antiseizure-medicine labeling) | Completed today | No thoughts of suicide |
| Survey | Gambling since the last visit: days, money lost, and urges (G-SAS for the past week) | Every visit | Completed today | No gambling for nine weeks; G-SAS 14 for the past week, from urges only |
| Self-management | Cognitive behavioral therapy for gambling disorder | Weekly sessions for at least 8 to 12 weeks, then as needed | Completed today | Weekly, with every session attended |
| Self-management | Self-exclusion from casinos and online gambling | At the start of treatment; renew and extend after any lapse | Up to date | In place |
| Self-management | Financial safeguards (bank gambling block, co-signer for large withdrawals, limited cash) | At the start of treatment | Up to date | Bank block and co-signer in place |
| Referral | Peer support (Gamblers Anonymous) | Offered at the start of treatment and after any lapse | Completed today | Two Gamblers Anonymous meetings attended |
| Referral | Debt counseling | Once, early in treatment | Completed today | Seen; repayment plan being drawn up |
| Medication safety | Medicine for gambling disorder (opioid antagonist) | Considered if psychological treatment alone is not enough | Not indicated | Responding to psychological treatment |

## Goal progress

- Reach the lamotrigine maintenance dose without rash by the two-month visit. Outcome by 1865-05-05: Maintenance dose of 100 mg twice daily reached after six weeks; no rash. **S**
- No seizures for six months after reaching the maintenance dose. In progress; target 1865-10-06. **S**
- Casino and online self-exclusion and a bank gambling block in place by the four-week visit. Outcome by 1865-03-03: Self-exclusion from casinos in the state and from licensed online sites, and a gambling block on his bank cards, in place. **S**
- No gambling through the eight-month visit. In progress; target 1865-10-06. **S**
- Written seizure action plan, safety counseling, and a SUDEP discussion completed by the four-week visit. Outcome by 1865-03-03: Plan written and shared with two friends; SUDEP discussed with the neurologist. **S**

## Guideline basis

- Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015), American Academy of Neurology and American Epilepsy Society (Neurology)
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018), American Academy of Neurology and American Epilepsy Society (Neurology)
- Psychological therapies for pathological and problem gambling (2012), Cochrane Database of Systematic Reviews
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge

## Follow-up

- Four-month review. Call the same day for a rash or a seizure. **S**
- Next scheduled visit 1865-07-07: four-month review of seizure control, mood, and gambling recovery. **S**
